Global Hematopoietic Stem Cells Transplantation Market Key Insights
During the forecast period of 2023-2035, the global hematopoietic stem cells transplantation market is expected to reach an estimated value of ~USD 6,000 billion by 2035, by expanding at a CAGR of ~15%. The market further generated a revenue of ~USD 2,500 million in the year 2022. Major key factors propelling the growth of hematopoietic stem cells transplantation market worldwide are the increasing prevalence of cancer and the rising prevalence of hematopoietic stem cell transplantation.
Market Definition of Hematopoietic Stem Cells Transplantation
Hematopoietic stem cell transplantation is a process of sourcing healthy multipotent stem cells for replacing the old degenerative cells of the body. After the transplantation of healthy hematopoietic stem cells in the patient’s body, they produce red blood cells, white blood cells, and platelets to repair and replace the patient’s hematopoietic system. The procedure is done to cure a disease, such as cancer, or bone marrow failure, and even in some cases to change the gene pattern. These cells are sourced from the umbilical cord of a baby, peripheral blood cells, and matching bone marrow.
Request Free Sample Copy of this Report @ https://www.researchnester.com/sample-request-3937
Global Hematopoietic Stem Cells Transplantation Market: Growth Drivers
The growth of the global hematopoietic stem cells transplantation market can majorly be attributed to the higher number of people suffering from cancer and the deaths attributed to cancer, followed by the growing adoption of hematopoietic stem cells transplantation. According to the World Health Organization, in 2020, around 10 million deaths were caused by cancer and it was known as the leading cause of death in the world. Moreover, every year, around 400,000 children develop cancer in the world. Furthermore, as of 2020, in the world, around 2 million hematopoietic cell transplants have been carried out in the world and there are around 1,500 transplantation centers are set up in the world. On the other hand, the market growth can also be attributed to the rising need for kidney transplantation. In order to stay alive, around 2 million people in the world need dialysis and kidney transplantation.
The global hematopoietic stem cells transplantation market is also estimated to grow majorly on account of the following:
• Rising Cases of Cancer
• Number of People Suffering from Organ Failure
• Rise in Research and Development on Stem Cells
• Increasing Number of Hematopoietic Stem Cells Transplant
• Development of Customized Drugs
Request for customization @ https://www.researchnester.com/customized-reports-3937
Global Hematopoietic Stem Cells Transplantation Market: Restraining Factor
Hematopoietic stem cells transplantation is also known to be associated with side effects to the heart, lungs, mouth, and others. Besides this, the cost of the treatment is very high and, in many places, there is a shortage of skilled experts who can perform the transplantation. Hence, these factors are expected to be the major hindrance to the growth of the global hematopoietic stem cells transplantation market during the forecast period.
Global Hematopoietic Stem Cells Transplantation Market Segmentation
• By Transplant Type (Allogenic, and Autologous)
• By Disease Type (Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma, Multiple Myeloma, and Others)
The multiple myeloma segment, amongst all the other segments, is anticipated to garner the largest revenue by the end of 2035. The growth of the segment can be attributed to the growing cases of multiple myeloma in the world and the surge in use of stem cell transplantation to treat multiple myeloma. In 2020, there were 131,518 cases of multiple myeloma for every 100,000 people, according to the IARC database. Furthermore, in the United States, around 34,000 adults are suffering from multiple myeloma. Moreover, nearly 13,000 people die of the disease in the nation, and approximately 120,000 deaths were reported worldwide in 2020.
• By Application (Bone Marrow Transplant (BMT), Peripheral Blood Stem Cells Transplant (PBSCT), Cord Blood Transplant (CBT), and Others)
• By Region
The North America hematopoietic stem cells transplantation market is anticipated to hold the largest market share by the end of 2035 among the market in all the other regions. The market size of North America is expected to grow on the account of rising cases of cancer and a higher number of transplants carried out in the region. The number of organ transplants carried out in the United States increased to 41,354 in 2021. It is approximately 6% higher than the previous higher. Furthermore, in 2022, around 61,000 new cases of leukemia were reported in the United States, and nearly 24,000 deaths were attributed to it.
Know More About the Complete Study @ https://www.researchnester.com/reports/hematopoietic-stem-cells-transplantation-market/3937
The market research report on global hematopoietic stem cells transplantation also includes the market size, market revenue, Y-o-Y growth, and key player analysis applicable for the market in North America (U.S., and Canada), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), and Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa).

Key Market Players Featured in the Global Hematopoietic Stem Cells Transplantation Market
Some of the key players of the global hematopoietic stem cells transplantation market are Escape Therapeutics, Inc., Regen BioPharma, Inc., ThermoGenesis Holdings, Inc., Lonza Group Ltd., CSG-BIO Company, Inc., CBR Systems, Inc., Pluristem Inc., Global Cord Blood Corporation, ViaCord, LLC, Cynata Therapeutics Limited, and others.
About Research Nester
Research Nester, which is a leading service provider for strategic market research and consulting services, aims to provide unbiased, unparalleled market insights and industry analysis. These analyses help conglomerates, executives, and industries to take wise decisions for their businesses as well as for their future marketing strategy, expansion and investment among others. We believe that our expertise in the field of market research can help businesses to expand to its new horizon. Our team of research analysts can provide businesses a right guidance at the right time, while our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.
Contact for more Info:
AJ Daniel
Email: [email protected]
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919